AMINOSYN 7% W/ ELECTROLYTES
LOE Approachingamino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride
NDAINJECTIONINJECTABLE
Approved
May 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 23h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AMINOSYN 7% W/ ELECTROLYTES is a parenteral nutrition solution containing amino acids, magnesium chloride, potassium phosphate, and sodium chloride administered by injection. It is used to provide essential amino acids and electrolytes to patients unable to meet nutritional needs orally, such as those in critical care or post-surgical recovery. The formulation supports protein synthesis and maintains electrolyte balance in hospitalized patients.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), indicating transition from maintenance to defensive positioning and potential reduction in marketing team investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AMINOSYN offers career opportunities primarily in operations, manufacturing, and supply chain—roles that support a stable, established product in the hospital formulary. This is ideal for professionals seeking hands-on manufacturing or technical roles rather than commercial or clinical advancement, with focus on cost optimization and process efficiency.
Assembly Technician
Worked on AMINOSYN 7% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.